2026 ICD-10-CM Diagnosis Code D86.89Sarcoidosis of other sites
ICD-10-CM Codes›D50–D89›D80-D89›D86
- Billable — Valid for Submission
- Chronic Condition
D86.89 is a billable ICD-10-CM diagnosis code for sarcoidosis of other sites. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 196 through 198. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Immunity disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Cerebral sarcoidosis
- Demyelination of central nervous system co-occurrent and due to neurosarcoidosis
- Esophagitis due to sarcoidosis
- Gastritis due to sarcoidosis
- Heerfordt's syndrome
- Hepatic granuloma
- Hepatic granulomas in sarcoidosis
- Lacrimal and parotid gland sarcoidosis
- Laryngeal granuloma
- Laryngeal sarcoidosis
- Myelitis due to sarcoidosis
- Nasal sarcoidosis
- Nasopharyngeal sarcoidosis
- Neurosarcoidosis
- Nodule of liver
- Nodule of nasal cavity
- Ocular sarcoidosis
- Parotid swelling
- Parotitis
- Sarcoid duodenitis
- Sarcoid neuropathy
- Sarcoidosis of digestive system
- Sarcoidosis of inferior turbinates
- Sarcoidosis of lacrimal gland
- Sarcoidosis of oral cavity
- Sarcoidosis of orbit
- Sarcoidosis with glomerulonephritis
- Splenic sarcoidosis
- Splenitis
- Swelling of salivary gland
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Hepatic granuloma
- Uveoparotid fever Heerfordt
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Deposit
- bone in Boeck's sarcoid - D86.89
- Fever (inanition) (of unknown origin) (persistent) (with chills) (with rigor) - R50.9
- uveoparotid - D86.89
- hepatic NEC - K75.3
- sarcoidosis - D86.89
- Heerfordt's disease - D86.89
- Osteitis - See Also: Osteomyelitis;
- tuberculosa - A18.09
- cystica - D86.89
- multiplex cystoides - D86.89
- Paralysis, paralytic (complete) (incomplete) - G83.9
- uveoparotitic - D86.89
- Polyneuropathy (peripheral) - G62.9
- sarcoidosis - D86.89
- Sarcoidosis - D86.9
- with
- hepatic granuloma - D86.89
- combined sites NEC - D86.89
- specified type NEC - D86.89
- Uveoparotitis - D86.89
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Deposit
- bone in Boeck's sarcoid
- Fever(inanition) (of unknown origin) (persistent) (with chills) (with rigor)
- uveoparotid
- Granuloma
- hepatic NEC
- in (due to)
- sarcoidosis
- Heerfordt's disease
- Osteitis
- tuberculosa
- cystica
- Osteitis
- tuberculosa
- multiplex cystoides
- Paralysis, paralytic(complete) (incomplete)
- uveoparotitic
- Polyneuropathy(peripheral)
- in (due to)
- sarcoidosis
- Sarcoidosis
- with
- hepatic granuloma
- Sarcoidosis
- combined sites NEC
- Sarcoidosis
- specified type NEC
- Uveoparotitis
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Mumps
an acute infectious disease caused by rubulavirus, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (from dorland, 28th ed)Parotitis
inflammation of the parotid gland.Rubulavirus
a genus of the family paramyxoviridae (subfamily paramyxovirinae) where all the species have hemagglutinin and neuraminidase activities but lack a c protein. mumps virus is the type species.Splenitis
inflammation of the spleen.Cerebral Sarcoidosis
sarcoidosis of the cerebrum.Mumps|Epidemic Parotitis|Epidemic Parotitis
a contagious viral infection caused by the mumps virus. symptoms include swollen and tender parotid glands, fever, muscle aches and fatigue. due to vaccination programs, mumps has become a rare disease.Parotitis
inflammation of the parotid glands.Suppurative Parotitis
parotitis that is caused by a bacterial agent.Laryngeal Granuloma
an inflammatory lesion of the vocal cords.
Patient EducationClinical
Sarcoidosis
Sarcoidosis is a condition in which groups of cells in your immune system form small, red, and swollen (inflamed) lumps. These lumps are called granulomas. They can form in any organ in the body. But they most commonly affect the lungs and lymph nodes in the chest. Over time, sarcoidosis can cause permanent scarring of organs.
The full article covers:
- What is sarcoidosis?
- What causes sarcoidosis?
- Who is more likely to develop sarcoidosis?
- What are the symptoms of sarcoidosis?
- What other problems can sarcoidosis cause?
- How is sarcoidosis diagnosed?
- What are the treatments for sarcoidosis?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D86.89 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D86.89Overview
Is D86.89 (Sarcoidosis of other sites) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report sarcoidosis of other sites on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does D86.89 group to?
When sarcoidosis of other sites is the principal diagnosis on an inpatient stay, it groups to MS-DRG 196, 197, 198, with relative weights from 0.7162 to 1.8872 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of D86.89?
Under the General Equivalence Mappings, sarcoidosis of other sites converts to ICD-9-CM 135 (sarcoidosis). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
